Can a mucosal microbiota signature predict disease severity, survival, and disease recurrence in PSC?

Phillipp Hartmann^{1

2

3}, Bernd Schnabl^{1

4}

Affiliations

¹ Department of Medicine, University of California San Diego, La Jolla, CA.
² Department of Pediatrics, University of California San Diego, La Jolla, CA.
³ Division of Gastroenterology, Hepatology and Nutrition Rady Children's Hospital San Diego, San Diego, CA.
⁴ Department of Medicine, VA San Diego Healthcare System, San Diego, CA.

Editorial

Phillipp Hartmann et al. Hepatology. 2023.

. 2023 Mar 1;77(3):709-711.

doi: 10.1097/HEP.0000000000000021. Epub 2023 Jan 3.

Phillipp Hartmann^{1

2

3}, Bernd Schnabl^{1

4}

¹ Department of Medicine, University of California San Diego, La Jolla, CA.
² Department of Pediatrics, University of California San Diego, La Jolla, CA.
³ Division of Gastroenterology, Hepatology and Nutrition Rady Children's Hospital San Diego, San Diego, CA.
⁴ Department of Medicine, VA San Diego Healthcare System, San Diego, CA.

No abstract available

Comment on

A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation.
Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR. Hole MJ, et al. Hepatology. 2023 Mar 1;77(3):715-728. doi: 10.1002/hep.32773. Epub 2023 Feb 17. Hepatology. 2023. PMID: 36056902 Free PMC article.

1. Hole MJ, Kaasen Jørgensen K, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, et al. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation. Hepatology. 2023;77:715–728.
1. Hov JR, Karlsen TH. The microbiome in primary sclerosing cholangitis: current evidence and potential concepts. Semin Liver Dis. 2017;37:314–331.
1. Hartmann P. The microbiome in hepatobiliary and intestinal disease. Front Physiol. 2022;13. doi: 10.3389/fphys.2022.893074 - DOI
1. Nakamoto N, Sasaki N, Aoki R, Miyamoto K, Suda W, Teratani T, et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat Microbiol. 2019;4:492–503.
1. Kummen M, Thingholm LB, Rühlemann MC, Holm K, Hansen SH, Moitinho-Silva L, et al. Altered gut microbial metabolism of essential nutrients in primary sclerosing cholangitis. Gastroenterology. 2021;160:1784–1798.e1780.